Interferon induced sarcoidosis with cutaneous involvement along lines of venous drainage in a former intravenous drug user.
Shuja
Fareesa
F
Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Kavoussi
Shaheen C
SC
Mir
Mohsin R
MR
Jogi
Reena P
RP
Rosen
Ted
T
D000998:Antiviral Agents / Q000009:adverse effects*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins; D012507:Sarcoidosis / Q000139:chemically induced*; D012871:Skin Diseases / Q000139:chemically induced*; D015819:Substance Abuse, Intravenous; D014680:Veins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b